{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:23:11Z","timestamp":1777285391787,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["200-2012-53584"],"award-info":[{"award-number":["200-2012-53584"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.vaccine.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T09:00:59Z","timestamp":1446800459000},"page":"167-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008\u20132011"],"prefix":"10.1016","volume":"34","author":[{"given":"Allison L.","family":"Naleway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew F.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julianne","family":"Gee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon K.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung Fu","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Vellozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.006_bib0100","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0105","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1016\/j.vaccine.2011.08.106","article-title":"Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink","volume":"29","author":"Gee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0110","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archpediatrics.2012.1451","article-title":"Safety of quadrivalent human papillomavirus vaccine administered routinely to females","volume":"166","author":"Klein","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0115","doi-asserted-by":"crossref","first-page":"f5906","DOI":"10.1136\/bmj.f5906","article-title":"Autoimmune, neurological, and venous thromboembolic adverse events after immunization of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study","volume":"347","author":"Arnheim-Dahlstrom","year":"2013","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0120","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.vaccine.2014.01.004","article-title":"Adverse events following immunization in Ontario's female school-based HPV program","volume":"32","author":"Harris","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.2014.2198","article-title":"Quadrivalent human papillomavirus vaccine and the risk of venous thromboembolism","volume":"312","author":"Scheller","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0130","unstructured":"Food and Drug Administration. October 16 2009 Approval Letter \u2013 Gardasil. Available at: www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm186991.htm [accessed 18.02.15]."},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.10.006_bib0135","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0962280208092342","article-title":"The methodology of self-controlled case series studies","volume":"18","author":"Whitaker","year":"2009","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0145","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1525-1497.2006.00458.x","article-title":"The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism","volume":"21","author":"Spencer","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0150","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ejvs.2002.1778","article-title":"Incidence of diagnosed deep vein thrombosis in the general population: systematic review","volume":"25","author":"Fowkes","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0165","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-2006-951293","article-title":"Epidemiology and risk factors of venous thromboembolism","volume":"32","author":"Ageno","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0170","doi-asserted-by":"crossref","first-page":"e812","DOI":"10.1542\/peds.2012-0267","article-title":"Trends in venous thromboembolism-related hospitalizations, 1994\u20132009","volume":"130","author":"Boulet","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0175","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.vaccine.2013.03.069","article-title":"Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink","volume":"31","author":"Naleway","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.thromres.2010.03.009","article-title":"Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States","volume":"126","author":"White","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.vaccine.2015.10.006_bib0185","unstructured":"Yih WH, Greene SK, Zichittella L, deJong JL, Gil-Prieto R, Griffin MR, et al. Mini-sentinel medical product assessment: evaluation of the risk of venous thromboembolism after gardasil vaccination. Available at: http:\/\/www.mini-sentinel.org\/assessments\/medical_events\/default.aspx [accessed April 29.04.15]."},{"key":"10.1016\/j.vaccine.2015.10.006_bib0190","series-title":"Adverse effects of vaccines: evidence and causality","author":"IOM (Institute of Medicine)","year":"2012"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15014176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15014176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T23:05:10Z","timestamp":1668639910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15014176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0264410X15014176"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008\u20132011","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}